Member Info for Laura2022

Dixy

They're historic results

It's the post period end details you need to look at

1).gold revenues started

2) historical claim settlemt is all but done

Does anyone know how much VAST night grt ?

This?

Zimbabwe

The Company has spent several years aiming to reach a satisfactory conclusion regarding the return of the historic claim. Very significant progress has recently been made. The Attorney General’s office has approved the terms of the settlement agreement relating to the historic claim and has recommended this to the relevant government body for signature. The fully executed settlement is currently awaited to enable the Company to complete the process of recovery and the Company remains confident of a successful conclusion

What does this refer to ?

Significant progress has been made by the parties relating to the historic claim. The Attorney General’s office has approved the terms of the settlement agreement relating to the historic claim and has recommended this to government for signature. The fully executed settlement is currently awaited to enable the Company to complete the process of recovery, and the Company remains confident of a successful conclusion

No

8 weeks ago 9p

2 weeks ago about 11-12

Here :

The Company continues to be successful in attracting repeat business this year from clients such as Merck KGaA, Numab Therapeutics and Bicycle Therapeutics, whilst also driving business with new clients.

No

Inaccurate in fact

Yes - there are contracts but they are small and mainly one-offs.

They are not small ( average size grown x 3 ) and not mainly one off

.most are repeat business

You clearly haven't read the annual report

Summary on BBC business page

Essentially very little change for ISA and AIM despite the armegeggon rumours last 6 weeks

Josh

I'm not playing anything..I'm simply correcting some of your inaccurate statements regarding clients/contracts /presentations

Good luck

Ad you've not replied here is a summary courtesy of Trench123 who posts here

23 mins : PS discusses the slide headed 'Immediate Growth Levers - Growth and Profit' and mentions that 'many of you will have seen this slide before as I have used it in a number of other presentations'. Firstly good to see the word 'Profit' mentioned, but secondly , I do not recall seeing this slide before, but I may well be mistaken. It could have been used to attract potential investors for the last funding round (it could also conceivably have been in presentations to potential future buyers/partners/long term investors)

26 mins & 32 mins : Much on the development and projected commercialisation of the personalised dosing tool through its partnership with DosemeRx. PS mentions mentions that he is 'conscious that we need to extract value from this tool'. He also notes we 'also intend to explore other avenues for this tool'. Looks like this is all progressing very well and could be transformative for PYC

27 mins/30 mins : Head of Modelling will be 'an expert in the field of modelling and simulation with broad networks across the industry'. Scheduled to start in November

29 mins : With reference to Biostatistics PS mentions ' We are exploring strategic options to enable accelerated growth' . 'This is something we are very much actively exploring at the moment'

31 mins : Scientific publications. 'Progressing a number of scientific papers at the moment' . 'Two have been submitted back to the respective journals and one is about to be submitted' PS mentions 'being able to credentialise your technical skills through peer reviews in scientific journals is a very important and very useful marketing tool for us'.

'Hopefully we can announce their publication very soon'

33 mins : PREDICT-ONC Trial at Blackpool Hospital 'going through final stages of ethical and regulatory approval'. 'We hope to announce the official start of the trial very soon' I though this would have been a little further advanced, but will presumably result in more of the Innovate grant income being reflected in the current financial year'. The end date of the trial remains unchanged

PS is highly organised and motivated and is building a very strong team to drive sustainable growth. I like what I see

Faramog

It's risen gently and steadily since mid August 9p ..where it was stupidly undervalued at cash

Welcome back after 8mths

Thanks Badster

I bought BEFORE today

Please see my posts

Probably helped

Now 16.25p

No

Health care/diagnostic/ research....GDR PYC etc

With PYC connections to CRUK, innovate etc you'd expect a big interest in our tech

Latino

Will be great for GDR PYC FAB etc

Reeves pledges research funding for engineering, biotechnology and medical science

published at 13:39

13:39

Reeves now lays out funding for the science sector.

She says the government will protect government investments in research and development "to unlock these growth industries of the future" with more than £20bn of funding,

The chancellor adds it will include at least £6.1bn to protect core research funding for areas like engineering, biotechnology and medical science.

0.98p.sell but can't seem to buy much ?